Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease

Abstract To assess the efficacy and safety of eltrombopag in connective tissue disease (CTD)-immune thrombocytopenia (ITP), we conducted this single-center retrospective observational study, including patients with refractory CTD-ITP who were treated with eltrombopag between January 2018 and August...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Juan Wang, Min Dai, Qiong Fu, Sheng Chen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/efe7af08d0f3455089981a6d8628972c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!